Azithromycin News and Research

RSS
Azithromycin, also known as Zithromax, belongs to the class of medicines known as antibacterials orantibiotics. These medicines kill bacteria (small organisms that can cause infection in humans) or stopbacteria from growing. Patients with weakened immune systems, includingpeople with HIV, tend to have more frequent andmore serious bacterial infections. Azithromycinwas approved by the FDA on June 14, 1996, formany uses, including the prevention and treatmentof Mycobacterium avium complex (MAC) inpersons with advanced HIV infection. It is alsobeing investigated to see how well it works inpreventing other kinds of bacterial infections inpeople with HIV.
Oxford University and ZOE join forces to widen access to COVID-19 treatment trials

Oxford University and ZOE join forces to widen access to COVID-19 treatment trials

Clinical trials of hydroxychloroquine in COVID-19 outpatients reported as safe

Clinical trials of hydroxychloroquine in COVID-19 outpatients reported as safe

Prednisone, Hydroxychloroquine best among COVID-19 treatments, claims large Spanish study

Prednisone, Hydroxychloroquine best among COVID-19 treatments, claims large Spanish study

Study identifies factors associated with death in critically ill COVID-19 patients

Study identifies factors associated with death in critically ill COVID-19 patients

Dutch trial of convalescent plasma in COVID-19 discontinued

Dutch trial of convalescent plasma in COVID-19 discontinued

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Low potassium levels in COVID-19 disease

Low potassium levels in COVID-19 disease

Life saving drug found for COVID-19 patients on ventilators

Life saving drug found for COVID-19 patients on ventilators

Hydroxychloroquine ineffective in animal SARS-CoV-2 infection

Hydroxychloroquine ineffective in animal SARS-CoV-2 infection

Hydroxychloroquine shows no antiviral effect on SARS-Cov-2 in non-human primate models

Hydroxychloroquine shows no antiviral effect on SARS-Cov-2 in non-human primate models

Anticardiolipin antibodies and COVID-19

Anticardiolipin antibodies and COVID-19

Tocilizumab in Critical COVID-19 Patients

Tocilizumab in Critical COVID-19 Patients

Study provides data on hydroxychloroquine outcomes for COVID-19 patients

Study provides data on hydroxychloroquine outcomes for COVID-19 patients

Health care providers urged to stop hydroxycholoroquine use for COVID-19

Health care providers urged to stop hydroxycholoroquine use for COVID-19

Does interferon therapy work in COVID-19?

Does interferon therapy work in COVID-19?

Researchers use optical mapping system to observe the effect of hydroxychloroquine

Researchers use optical mapping system to observe the effect of hydroxychloroquine

Study examines changes in prescription patterns during COVID-19 pandemic

Study examines changes in prescription patterns during COVID-19 pandemic

My mother died of the coronavirus. It’s time she was counted.

My mother died of the coronavirus. It’s time she was counted.

Zero benefit of Hydroxychloroquine or Chloroquine in COVID-19, says extensive study

Zero benefit of Hydroxychloroquine or Chloroquine in COVID-19, says extensive study

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients